摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(3-ethoxycarbonyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobut-2-enoic acid | 380158-17-8

中文名称
——
中文别名
——
英文名称
4-[(3-ethoxycarbonyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobut-2-enoic acid
英文别名
——
4-[(3-ethoxycarbonyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobut-2-enoic acid化学式
CAS
380158-17-8
化学式
C16H19NO5S
mdl
——
分子量
337.397
InChiKey
QYPHUICUJZHSLJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    121
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[(3-ethoxycarbonyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobut-2-enoic acid硫脲1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 生成 ethyl 2-{[(2-imino-4-oxo-1,3-thiazolidin-5-yl)acetyl]amino}-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate
    参考文献:
    名称:
    Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors
    摘要:
    Secreted frizzled related protein-1 (sFRP-1) inhibitors have the potential to be used for the treatment of osteoporosis or other bone related disorders, since the level of sFRP-1 affects osteoblast apoptosis and proliferation. From high throughput screening, we have identified a class of iminooxothiazolidines as sFRP-1 inhibitors. Structure-activity relationships were established for various regions of the scaffold along with the biochemical characterization of this class to probe selectivity, binding and ex vivo activity. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.09.085
  • 作为产物:
    参考文献:
    名称:
    Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors
    摘要:
    Secreted frizzled related protein-1 (sFRP-1) inhibitors have the potential to be used for the treatment of osteoporosis or other bone related disorders, since the level of sFRP-1 affects osteoblast apoptosis and proliferation. From high throughput screening, we have identified a class of iminooxothiazolidines as sFRP-1 inhibitors. Structure-activity relationships were established for various regions of the scaffold along with the biochemical characterization of this class to probe selectivity, binding and ex vivo activity. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.09.085
点击查看最新优质反应信息

同类化合物

酮替芬EP杂质A 酮替芬 苯噻啶苹果酸盐 苯噻啶盐酸盐 苯噻啶 益托洛替芬 富马酸酮替芬 去甲酮替芬富马酸氢盐 乙基2-[(乙基氨基甲硫杂酰)氨基]-5,6,7,8-四氢-4H-环庚三烯并[b]噻吩-3-羧酸酯 [2,3-d]噻吩并环庚三烯酮 9-氧代酮替芬 9,10-二溴-9,10-二氢-4H-苯并[4,5]环庚并[1,2-b]噻吩-4-酮 9,10-二氧代酮替芬 9, 10-二氢-4H-苯并[4, 5]环庚三烯[1, 2-b]噻吩-4-酮 6H-环庚三烯并[c]噻吩-6-酮,1,3,5,7-四甲基- 5,6,7,8-四氢-4h-环庚基[b]噻吩-2-羧酸 5,6,7,8-四氢-4H-环庚[b]噻吩-2-羧酸酰肼 4H-环庚三烯并[b]噻吩-3-羧酸,5,6,7,8-四氢-2-[3-(羟甲基)-5-甲基-4H-1,2,4-三唑-4-基]-,甲基酯 4-羟基酮替芬 4-(哌啶-4-亚基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-10(9H)-酮 4-(3'-甲基氨基丙基亚基)-9,10-二氢-4H-苯并(4,5)环庚并(1,2-b)噻吩 4,9-二氢-4-(1-甲基-4-哌啶基亚基)-10H-苯并[4,5]环庚三烯并[1,2-b]噻吩-10-酮 N-氧化物; 酮替芬 N-氧化物 2-溴-9,10-二氢-4H-苯并(4,5)环庚并(1,2-b)噻吩-4-酮 2-氯-N-(3-氰基-5,6,7,8-四氢-4H-环戊并[b]噻吩-2-基)-乙酰胺 2-氨基环庚烷并[B]噻吩-3-羧酸乙酯 2-氨基-N-甲基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-甲酰胺 2-氨基-N-乙基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-甲酰胺 2-氨基-5,6,7,8-四氢-4H-环庚基[b]噻吩-3-羧酰胺 2-氨基-5,6,7,8-四氢-4H-环庚基[b]噻吩-3-甲腈 2-氨基-5,6,7,8-四氢-4H-环庚[B]噻吩-3-甲酸甲酯 2-乙酰氨基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-羧酸 2-[(3-氯-1-氧代丙基)氨基]-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-羧酸乙酯 2-(2-氯乙酰基氨基)-5,6,7,8-四氢-4H-环庚[b]噻吩-3-羧酸乙酯 10-甲氧基-4H-苯并[4,5]环庚三烯并[1,2-b]噻吩-4-酮 10-甲氧基-4-(1-甲基-4-哌啶基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-4-醇 1,3-二氢-1-[1-[(5,6,7,8-四氢-4H-环庚[b]噻吩-2-基)羰基]-4-哌啶基]-2H-苯并咪唑-2-酮 (3E)-3-(9,10-二氢-4H-苯并[4,5]环庚三烯并[1,2-b]噻吩-4-亚基)-N,N-二甲基丙烷-1-胺 (+/-)-10-<3-Dimethylamino-propyl>-4,5-dihydro-10H-benzo<5,6>cyclohepta<1,2-b>thiophen-10-ol methyl 2-[3-(acetylamino)-6-methyl-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl]acetate 10-<3-Dimethylamino-propyliden>-4,5-dihydro-10H-benzo<5,6>-cyclohepta<1,2-b>thiophen ethyl 3-[4-(1-methylpiperidin-4-ylidene)-10-oxo-9,10-dihydro-4H-1-thiabenzo[f]azulen-2-yl]acrylate 2-t-butoxycarbonylamino-4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene ethyl 4-[1-(2-ethoxyethyl)piperidin-4-ylidene]-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylate hydrochloride Ethyl 4-(1-propylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylate hydrochloride 4-(6-chloro-2-methyl-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methyl-piperidine methyl 2-[2-(acetylamino)-6-methyl-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl]acetate 2-ureidomethyl-4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene 2-[2-(9,10-dihydro-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-ethyl]-piperidine-1-carboxylic acid ethyl ester 4-[1-(2-ethoxyethyl)piperidin-4-ylidene]-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylic acid